Judo Bio Secures $100M Financing to Advance Kidney-Targeted Oligonucleotide Medicines October 10, 2024
Odyssey Therapeutics Appoints Timothy P. Walbert and Ian F. Smith to Board of Directors October 7, 2024
Robert Johnson Joins College of American Pathologists as SVP of Communications and Marketing October 7, 2024